Literature DB >> 1985866

Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread.

D Theodorescu1, I Cornil, C Sheehan, S Man, R S Kerbel.   

Abstract

We have previously shown, using tumor cell populations genetically tagged by random integrations of plasmid DNA, that metastatically-competent clonal cell variants have a strong growth advantage within primary tumors over their non-metastatic counterparts. As a result, primary tumors can become overgrown by the progeny of such cells, a process referred to as "clonal dominance" of primary tumors by metastatically-competent cells. Because of the well-known "metastatic inefficiency" of the multi-step cascade process of spread and growth, clonal dominance within primary tumors may be necessary for distant metastatic spread or increase the probability of its occurrence. To examine this hypothesis mice were inoculated s.c. with mixture of non-metastatic and genetically tagged, metastatically-competent mouse mammary carcinoma cells in defined ratios, but always containing an excess of the unmarked non-metastatic population. Progressive overgrowth of the metastatic subpopulation was monitored as a function of time by Southern analysis of DNA obtained from mixed primary tumors. This allowed us to evaluate the effects that surgical removal of the primary tumor had before, during and after effective clonal dominance, and what influence this had on the subsequent formation of distant metastases. Surgical removal of primary tumors before metastatic clonal dominance resulted in a low (0.25%) frequency of lung metastases, whereas removal just 1 or 2 weeks later during or after clonal dominance was achieved resulted in a high (75-100%) frequency of such metastases. Our results support the hypothesis that dominance of primary tumors by metastatically competent cells may be necessary for distant metastatic spread, and also suggest that clonal interactions play a significant role in modulating the metastatic ability of tumor cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985866     DOI: 10.1002/ijc.2910470121

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Partonomies for interactive explorable 3D-models of anatomy.

Authors:  R Schubert; K H Höhne
Journal:  Proc AMIA Symp       Date:  1998

2.  Investigation of solid tumor progression with account of proliferation/migration dichotomy via Darwinian mathematical model.

Authors:  Maxim Kuznetsov; Andrey Kolobov
Journal:  J Math Biol       Date:  2019-10-01       Impact factor: 2.259

3.  Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions.

Authors:  J W Rak; R S Kerbel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

4.  Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization.

Authors:  J F Simpson; D E Quan; J P Ho; M L Slovak
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

5.  Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis.

Authors:  R K Singh; R Tsan; R Radinsky
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

6.  Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines.

Authors:  S M Nielsen-Preiss; J P Quigley; J E Testa
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 7.  Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions.

Authors:  J Guy Lyons; Erwin Lobo; Anna M Martorana; Mary R Myerscough
Journal:  Clin Exp Metastasis       Date:  2007-12-11       Impact factor: 5.150

8.  Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.

Authors:  C Lu; M F Vickers; R S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression.

Authors:  J Jouanneau; G Moens; Y Bourgeois; M F Poupon; J P Thiery
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.